Hydroxamic acids and acyl hydroxamines as naaladase inhibitors

Details for Australian Patent Application No. 2002256505 (hide)

International Classifications

Event Publications

1 May 2003 Application Open to Public Inspection

Published as AU-B-2002256505

26 June 2008 Application Accepted

Published as AU-B-2002256505

23 October 2008 Standard Patent Sealed

8 January 2009 Assignment Registered

Guilford Pharmaceuticals Inc. The patent has been assigned to MGI GP, Inc.

26 March 2009 Assignment Registered

MGI GP, Inc. The patent has been assigned to Eisai Corporation of North America

21 January 2010 Assignment Registered

Eisai Corporation of North America The patent has been assigned to Eisai Inc.

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.